Exercise study aims to boost quality of life for men with metastatic prostate cancer
NCT ID NCT07572760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a low to moderate load power training program can improve quality of life, strength, and balance in men with metastatic prostate cancer who are on hormone therapy. About 66 participants will either join a supervised exercise program twice a week for 6 months or continue with routine care. Researchers will measure changes through fitness tests and questionnaires.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alicante
RECRUITINGSan Vicent del Raspeig, Alicante, 03690, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Half the dose, same hope? trial tests cutting hormone therapy in prostate cancer
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Hormone therapy showdown: can an oral pill beat the shot for prostate cancer patients?
- Can a new daily pill slow advanced prostate cancer?
- Immunotherapy combo takes on Hard-to-Treat prostate cancer